Eli Lilly Gets European Approval to Sell Trulicity, a Type 2 Diabetes Drug by DAVID JOLLY

By DAVID JOLLY

The move by the European Commission puts pressure on the company’s Danish rival, Novo Nordisk, the market leader in its category.

Published: November 26, 2014 at 12:00AM

from NYT Business Day http://ift.tt/1y7L2s4

from WordPress http://ift.tt/11SNwyP

via Hadi Aboukhater